chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Bone pain, Diarrhoea, Feeling cold, Influenza like illness
Clinical narrative: felt weak; bones sore; felt cold; vomiting; diarrhea; flu like symptoms; bones stiff; arm was sore; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received on 30th September 2020, for tolerance refer case US2021AMR008922).   On 5th December 2020, the patient received the 2nd dose of Shingrix. On 6th December 2020, 1 days after receiving Shingrix, the patient experienced weakness, bone pain, feeling cold, vomiting, diarrhea, influenza-like symptoms and stiffness. On an unknown date, the patient experienced pain in arm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm, weakness, bone pain, feeling cold, vomiting, diarrhea, influenza-like symptoms and stiffness were recovered/resolved.   It was unknown if the reporter considered the pain in arm, weakness, bone pain, feeling cold, vomiting, diarrhea, influenza-like symptoms and stiffness to be related to Shingrix.  Additional details were provided as follows: On 6th December 2020 morning, the patient felt weak, her bones were sore and stiff, had diarrhea and vomiting, felt cold and flu like symptoms. Her arm was sore again for 2 days. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021021112:same reporter US-GLAXOSMITHKLINE-US2021AMR008922:same reporter
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Musculoskeletal stiffness, Pain in extremity, Vomiting
Clinical narrative: felt weak; bones sore; felt cold; vomiting; diarrhea; flu like symptoms; bones stiff; arm was sore; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received on 30th September 2020, for tolerance refer case US2021AMR008922).   On 5th December 2020, the patient received the 2nd dose of Shingrix. On 6th December 2020, 1 days after receiving Shingrix, the patient experienced weakness, bone pain, feeling cold, vomiting, diarrhea, influenza-like symptoms and stiffness. On an unknown date, the patient experienced pain in arm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm, weakness, bone pain, feeling cold, vomiting, diarrhea, influenza-like symptoms and stiffness were recovered/resolved.   It was unknown if the reporter considered the pain in arm, weakness, bone pain, feeling cold, vomiting, diarrhea, influenza-like symptoms and stiffness to be related to Shingrix.  Additional details were provided as follows: On 6th December 2020 morning, the patient felt weak, her bones were sore and stiff, had diarrhea and vomiting, felt cold and flu like symptoms. Her arm was sore again for 2 days. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021021112:same reporter US-GLAXOSMITHKLINE-US2021AMR008922:same reporter
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site irritation, Left-handedness, Mobility decreased, Pain in extremity, Product administered at inappropriate site
Clinical narrative: arm pain/has gotten bad again; can't lift her left arm; vaccine that is irritating her muscle; believes that the vaccine was either injected incorrectly; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th October 2020, the patient received the 1st dose of Shingrix. On 28th October 2020, less than a day after receiving Shingrix, the patient experienced pain in arm, mobility decreased, injection site irritation and vaccine administered at inappropriate site. On an unknown date, the outcome of the pain in arm and mobility decreased were not recovered/not resolved and the outcome of the injection site irritation and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the pain in arm, mobility decreased and injection site irritation to be related to Shingrix.  Additional details were provided as follows:  After receiving 1st dose of Shingrix, the patient experienced arm pain and she still could not lift her left arm. The patient was also left-handed. The patient reported that the pain had improved a little after doing PT, however, it had gotten bad again even though she was still doing PT at home. The reporter believed that ,the vaccine was either injected incorrectly or there was something in the vaccine that was irritating her muscle, which led to vaccine administered to inappropriate site. The reporter consent to follow up.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site rash, Pain in extremity
Clinical narrative: Rash around the injection site; Soreness of the injection arm; This case was reported by a consumer via call center representative and described the occurrence of injection site rash in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th January 2021, the patient received the 1st dose of Shingrix (intramuscular). On 26th January 2021, less than a day after receiving Shingrix, the patient experienced pain in arm. On 27th January 2021, the patient experienced injection site rash. On 27th January 2021, the outcome of the pain in arm was recovered/resolved. On 28th January 2021, the outcome of the injection site rash was recovered/resolved.   The reporter considered the injection site rash and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. The reporter stated that, the patient received Shingrix vaccine approximately ten days ago. On the dayof vaccination the patient had soreness of the injection arm and the day after the vaccination, had a rash around the injection site. The symptoms have resolved. The reporter consented to follow up. This case was lined with case US2021030895, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021030895:same reporter
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain lower, Neuralgia, Pain
Clinical narrative: Burning pain; Nerve pain; pain was in a band of 4-6 inches wide that started at the lower portion of her abdomen; This case was reported by a consumer via call center representative and described the occurrence of pain burning in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included rheumatoid arthritis. Concomitant products included methotrexate.   In August 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 1 month after receiving Shingrix, the patient experienced pain burning, nerve pain and lower abdominal pain. The patient was treated with gabapentin. On an unknown date, the outcome of the pain burning, nerve pain and lower abdominal pain were recovered/resolved.   It was unknown if the reporter considered the pain burning, nerve pain and lower abdominal pain to be related to Shingrix.  Additional details were provided as follows: The reporter was reported for herself. The age at vaccination was not reported. The patient received dose of Shingrix in right deltoid. The patient received 1st dose of the Shingrix vaccine at the pharmacy at the end of August 2020. A months later the patient had burning, nerve pain and the pain was in a band of 4-6 inches wide that started at the lower portion of her abdomen and wrapped around to the side. The reporter stated that, it lasted for 4 to 6 weeks. The patient went to doctor and was gabapentin for the nerve pain. The patient has been taking methotrexate for rheumatoid arthritis for about 2.5 years. The patient would scheduled to receive the 2nd dose on the day of reporting. The reporter consented to follow up.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Abdominal pain
Clinical narrative: bad abdominal pain; This case was reported by a consumer via call center representative and described the occurrence of abdominal pain in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included shingles (had shingles from September through December 2020) and acid reflux (oesophageal) (had acid reflux and procedure to treat acid reflux).   On 3rd February 2021, the patient received the 1st dose of Shingrix (intramuscular). On 4th February 2021, 1 days after receiving Shingrix, the patient experienced abdominal pain. On an unknown date, the outcome of the abdominal pain was recovering/resolving.   It was unknown if the reporter considered the abdominal pain to be related to Shingrix.  Additional details were provided as follows: The reporter reported for himself. The patient received 1st dose of Shingrix in the left arm. By the thursday on 4th February 2021, the patient experienced abdominal pain and was now slowly getting better. The reporter did not consent to follow up. This case was linked with case US2021034626, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021034626:same reporter
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: vaccine administered to 17.5 year old; A spontaneous report was received from a Healthcare Professional, concerning a patient of 17.5-year-old and was administered the Moderna vaccine (mRNA-1273).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) through an unknown route in an unknown arm for prophylaxis of COVID-19 infection.   On an unknown date, the pharmacy accidentally vaccinated a 17.5-year-old patient with the first dose of Moderna COVID vaccine.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The outcome of event, vaccine administered to 17.5-year-old was considered as resolved on an unknown date.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (17.5 year old) for mRNA-1273 (lot number unknown) with no associated AEs reported.
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: the syringe came off and the needle stayed in his arm, the serum was everywhere.; A spontaneous report was received from a Healthcare Professional concerning a male patient, of approximately 50-60 years of age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced vaccination device connection issue.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On an unknown date, the patient received their first of two planned doses of mRNA-1273 (lot/batch: if reported or unknown) for prophylaxis of COVID-19 infection.  On 11 Jan 2021, the patient experienced as reported, the syringe came off and the needle stayed in his arm, the serum was everywhere.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.  At the time of this report, the outcome of the event(s) (The syringe came off and the needle stayed in his arm, the serum was everywhere) was unknown.; Reporter's Comments: This report refers to a case of Vaccine underdose and syringe connection issue for mRNA-1273 with no associated AEs.
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Younger than 18 patient received the shot; A spontaneous report was received from a pharmacist concerning a patient who experienced the following: younger than 18 patient received the shot.    The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On an unknown date, prior to the onset of the event, the patient received a dose of mRNA-1273 (Batch number not provided, not specified if 1st or 2nd dose) for prophylaxis of COVID-19 infection.    On an unknown date, the patient was younger than 18 and received vaccination. Treatment information was not provided.    Action taken with mRNA-1273 in response to the event was not provided.  The outcome of the event younger than 18 patient received the shot was resolved.; Reporter's Comments: This report refers to a case of inappropriate age at vaccine administration for mRNA-1273 (Batch number not provided, not specified if 1st or 2nd dose)  with no associated AEs.; Sender's Comments:  MOD21-032350:Same reporter
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure via skin contact, Underdose
Clinical narrative: Vaccine dripping out on arm; Vaccine dripping out on arm; A spontaneous report was received from a consumer concerning an 80-years-old, male patient who experienced vaccine dripping out on arm.    The patient's medical history included chronic obstructive pulmonary disease (COPD) and diabetes. Concomitant product use was not provided by the reporter.   On 17 Feb 2021, prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 [Lot number 0bIL20A] intramuscularly for prophylaxis of COVID-19 infection.    On 17 Feb 2021, the patient experienced vaccine dripping out and going down his arm. Treatment information was not provided.    The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.  The event vaccine dripping out on arm was considered recovered/resolved on 17 Feb 2021.; Reporter's Comments: This report refers to a case of vaccine underdose and exposure via skin for mRNA-1273 [Lot number 0bIL20A] with no associated AEs.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old received moderna vaccine; A spontaneous report was received from a pharmacist regarding a 17-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) with inappropriate age at vaccination administration.  The patient's medical history was not included. Concomitant medications were not provided.   On 16 Feb 2021, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Lot number: 016M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.    On 16 Feb 2021, it was noticed after the vaccine was given that the patient was not the correct age to receive the vaccine. Her age is reported as 17.  No side effects were reported and treatment was not given.  Action taken with mRNA-1273 was not reported.  The outcome of the event, receiving the vaccine at an inappropriate age, was considered resolved.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273.  There were no reported adverse events associated with this case.
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Patient was given 0.3 ml dose; A spontaneous report was received from a Consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced accidental underdose of vaccine.    The patient's medical history was not provided. No relevant concomitant medications were reported.    On an unknown date, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) for prophylaxis of COVID-19 infection.  On an unknown date, the patient was given 0.3 ml dose of the COVID-19 vaccine. No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.  At the time of this report, the outcome of the event (accidental underdose) was recovered/resolved  The reporter did not assess causality for the reported event.; Reporter's Comments: This case concerns a female of unknown age who experienced nonserious unexpected events of Accidental underdose with mRNA-1273 (lot # unknown) without associated adverse events.  The patient was given 0.3 ml dose of the COVID-19 vaccine. The events occurred the same day as the first dose of mRNA-1273.  Event reported as resolved.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: vaccine administered at 16 years old; A spontaneous report was received from a Consumer concerning a 17 year-old male patient who experienced vaccine administered at 16 years old/ MedDRA PT: product administered to patient of inappropriate age.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On an unknown date, the patient received the first of two planned doses of mRNA-1273 (batch: unknown) for prophylaxis of COVID-19 infection.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.  At the time of this report, the outcome of the event, vaccine administered at 16 years old was resolved on an unknown date.; Reporter's Comments: This report refers to a case of inappropriate age at vaccine administration for mRNA-1273 (batch: unknown) with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Ocular hyperaemia, Uveitis, Vaccination site pain
Clinical narrative: Uveitis; pain around my left eye and the eye ball; eye ball was also red; Sore arm; A spontaneous report (United States) was received from a consumer who was also a 69-year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  a sore arm, pain around her left eye and eye ball, eye red, and uveitis.  The patient's medical history was not reported. Products known to have been used by the patient, within two weeks prior to the event, included lisinopril, escitalopram oxalate and omeprazole.  On 14 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 006M20A) intramuscularly in the left arm shoulder deltoid muscle for prophylaxis of COVID-19 infection.   On date 16 Feb 2021, the patient had a sore arm, pain around her left eye and eye ball and eye was red. The patient experienced a condition called uveitis. Treatment for the event included Pred-Forte eye drops.  Action taken with mRNA-1273 in response to the events was not reported.    The outcome of the events is unknown.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chronic obstructive pulmonary disease, Dyspnoea, Heart rate increased, Musculoskeletal discomfort
Clinical narrative: severe COPD; could not breathe; chest pressure; pressure in the neck; rapid heartrate; premature ventricular contractions, extra heart beat; face swollen a little; A spontaneous report was received from a consumer concerning a 71-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273)  experienced severe COPD, could not breathe, had chest pressure, pressure in the neck, rapid heartrate (have extra heartbeat), premature ventricular contractions and swelling in face.  No prior medical history and concomitant medications were reported.     On 11 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.     The patient experienced the events like severe COPD, could not breathe, had chest pressure, pressure in the neck, rapid heartrate (have extra heartbeat), premature ventricular contractions and swelling in face on 12 Feb 2021.  The reported case is serious as the events, severe COPD, could not breathe, had chest pressure, pressure in the neck, rapid heartrate (have extra heartbeat), premature ventricular contractions and swelling in face lead to hospitalization and resulted in prolonged hospitalization.  Action taken with mRNA-1273 in response to the events was not reported.     The outcome of the events were considered not resolved and the patient is still in.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling face, Ventricular extrasystoles
Clinical narrative: severe COPD; could not breathe; chest pressure; pressure in the neck; rapid heartrate; premature ventricular contractions, extra heart beat; face swollen a little; A spontaneous report was received from a consumer concerning a 71-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273)  experienced severe COPD, could not breathe, had chest pressure, pressure in the neck, rapid heartrate (have extra heartbeat), premature ventricular contractions and swelling in face.  No prior medical history and concomitant medications were reported.     On 11 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.     The patient experienced the events like severe COPD, could not breathe, had chest pressure, pressure in the neck, rapid heartrate (have extra heartbeat), premature ventricular contractions and swelling in face on 12 Feb 2021.  The reported case is serious as the events, severe COPD, could not breathe, had chest pressure, pressure in the neck, rapid heartrate (have extra heartbeat), premature ventricular contractions and swelling in face lead to hospitalization and resulted in prolonged hospitalization.  Action taken with mRNA-1273 in response to the events was not reported.     The outcome of the events were considered not resolved and the patient is still in.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Drooling, Dysphagia, Hypoaesthesia, Injection site hypoaesthesia, Injection site pain
Clinical narrative: burning in arm at injection site; numbness in arm at injection site; Hard to swallow; saliva was coming out of Lips; numbness spread from shoulder to neck to back of head, around front of head down to face and to lip; A spontaneous report was received from a reporter(Health care professional) concerning 51 year old, female patient , who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced burning and numbness in arm at the site of injection, numbness spread from shoulder to neck to back of head, around front of head down to face and to lip, drooling, dysphagia.  The patient medical history was not provided. The relevant concomitant medications were also not provided.  On 31-DEC-2020, prior to the consent of the events, the patients received one dose of mRNA-1273(batch number: 026L20A) through intramuscularly in the left arm for prophylaxis of COVID-19 injection.  On 31-DEC2021, the patient experienced injection site pain, burning,  numbness in arm, shoulder, neck, back of the head, lip and face, hard to swallow and drooling. The patient had undergone CT scan of head, MRI of the brain with contrast, Chest X-ray ang EKG as well as lab work. She was referred to a neurologist and has an April appointment. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events were resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: would come down with the flue every time; Initial information received on 15-Oct-2020 regarding an unsolicited valid non-serious case from a consumer via media.  This case involves patient of unknown demography who would come down with the flue every time (influenza), after receiving INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient would come down with the flue every time (influenza, non serious) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was not reported for the event influenza.  There will be no information on the batch number for this case.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Blood test, Computerised tomogram, Facial paresis, Magnetic resonance imaging
Clinical narrative: Bell Palsy, Rt face weakness, Adult.  Treating with Valacyclovir HCL 1gm tab #21/21, 1 tab for 7 days; and Prednisone 20mg tab, 3 tabs per day for 7 days.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Scan with contrast, Urine analysis
Clinical narrative: Bell Palsy, Rt face weakness, Adult.  Treating with Valacyclovir HCL 1gm tab #21/21, 1 tab for 7 days; and Prednisone 20mg tab, 3 tabs per day for 7 days.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Skin warm
Clinical narrative: Nausea, headache, dizzy, warm hand
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Red blood cell sedimentation rate normal
Clinical narrative: Three days after initial vaccination, she developed a severe occipital headache, otherwise without photophobia, phonophobia, nausea, nuchal rigidity, fever, chills, myalgias, arthralgias, or altered mental status. The headache has persisted for 1 month post-vaccination.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash macular
Clinical narrative: Itching on hands and forearms that  started 2-3 days after shot and then blotches appeared btween 4-5 days after shot
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Eye swelling, Fatigue, Heart rate increased, Injection site erythema
Clinical narrative: On 2/17 woke up with 102.3 fever, tongue, lips, eyes swollen, inside mouth/throat irritated, injection site red and swollen, tingling down left arm extreme fatigue. Increased Blood Pressure and Heart rate
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Lip swelling, Paraesthesia, Pyrexia, Stomatitis
Clinical narrative: On 2/17 woke up with 102.3 fever, tongue, lips, eyes swollen, inside mouth/throat irritated, injection site red and swollen, tingling down left arm extreme fatigue. Increased Blood Pressure and Heart rate
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue
Clinical narrative: On 2/17 woke up with 102.3 fever, tongue, lips, eyes swollen, inside mouth/throat irritated, injection site red and swollen, tingling down left arm extreme fatigue. Increased Blood Pressure and Heart rate
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope, Vital signs measurement
Clinical narrative: Client had a full syncopal episode while getting up after his advised post vaccination observation time @0842. Client had an unassisted fall and witness said incident occurred for 45 seconds. Client was then assisted to his seat by our medical staff and evaluated. Client advised for complete medical evaluation at the ER in which he was hesitant at first, but then cooperated. Client verbalized no head trauma or hx of syncopal episodes. EMS arrived to transport client to Emergency care @ 0852.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Syringe issue
Clinical narrative: All of the vaccine leaked at the time of administration due to faulty syringe.  Patient was appropriately re vaccinated per guidelines.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Rash, Skin warm
Clinical narrative: Moderna rec'd 2/28 and had sharp pain in right temple that wasnt consistent, and this lasted for a couple hours. Throughout the day I could still feel it but it finally subsided and I've not felt it any more.  I also developed a rash that started the same evening  because I felt this heat in my torso area and then I had a rash all over torso.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Later that day after the vaccination I developed a severe migrane headache that lasted 2 weeks.  After a few days I went to see my PCP who prescribed a Medrol dose pack and muscle relaxer to help with the pain but the headache still remained the 2 weeks before it finally went away
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory rate increased
Clinical narrative: At 11: 14 am the recipient reported a change in her breathing, stating it was faster. The recipient was checked out by EMS and signed a refusal to the hospital. The recipient stated she was nervous about getting her shot.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dizziness, Fatigue, Feeling abnormal, Hypertension
Clinical narrative: on 2/27/21 I experienced fatigue and body aches, as well as sore injection site.   on 3/1/21 I felt fine during the day but at 9 PM I experienced severe dizziness and fatigue.  My blood pressure went to 168/85. on 3/2/21 I felt better, BP was 126/64 at 9 AM.  Still fatigued and an upset stomach.  Foggy in the head and still fatigued.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain
Clinical narrative: on 2/27/21 I experienced fatigue and body aches, as well as sore injection site.   on 3/1/21 I felt fine during the day but at 9 PM I experienced severe dizziness and fatigue.  My blood pressure went to 168/85. on 3/2/21 I felt better, BP was 126/64 at 9 AM.  Still fatigued and an upset stomach.  Foggy in the head and still fatigued.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Reported symptoms daily to V-Safe immediately following date vaccine was given. After that process was completed, "Covid Arm" began on 2/26/2021 as red patch on left arm (injection site), about 3" diameter. As of this morning 3/2/2021, patch has expanded around upper arm towards body, now about 6" long in a more rectangular pattern. Still bright red, tender to touch but not particularly itchy. Reported initial event to PCP who agreed it is harmless, as I had read, and asked me to monitor and report to her if other symptoms (fever etc) presented. So far, no fever.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Mobility decreased, Skin warm
Clinical narrative: Right  side of face hot feeling  and reddening with numbing feeling  in check  ,lips jaw, lasting  about 5 to 6 hrs then pain from my neck and whole  shoulder socket down  to my hand all on th right side skin extremely  sensitive  to touch, hot to touch with  swelling very  limited range Unable to extend  arm outward as of 03/02/2021 @ 12:15 a.m. .  Ibuprofen  and Tylenol taken through  the night with not much relief now trying  aleeve if not feeling  better  tomorrow  may need  to  see primary dr. Also had a very strange bitter/metal  taste to my lips and mouth  when they were feeling  hot and numbing.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pain, Pyrexia
Clinical narrative: High fever (102), aches, chills/shivering, nausea,  extreme fatigue, rash (local)
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: High fever (102), aches, chills/shivering, nausea,  extreme fatigue, rash (local)
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Itchy rash all over abdomen
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site extravasation, Injection site pain, Injection site pruritus, Injection site reaction, Injection site swelling
Clinical narrative: After her second dose, she reported some vaccine product leaking from the injection site as the needle was removed. She subsequently developed pain/pruritis and an erythematous rash with swelling at the injection site the next day. Pain was localized to the muscle at the surface of the skin. The pain at the skin resolved after 2 days. She still has some soreness in the muscle today
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Occupational exposure to product, Rash erythematous, Underdose
Clinical narrative: After her second dose, she reported some vaccine product leaking from the injection site as the needle was removed. She subsequently developed pain/pruritis and an erythematous rash with swelling at the injection site the next day. Pain was localized to the muscle at the surface of the skin. The pain at the skin resolved after 2 days. She still has some soreness in the muscle today
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Loss of consciousness, Tremor, Vertigo
Clinical narrative: Three hours after shot I started getting dizzy.  For 4 hours after I was Extremely dizzy, vomited, bad shaking chills.  It was so sever I wanted to go to ER and be put unconsious.  My husband made so many calls for information on help and no one answered until this morning March 2.  I didn't feel that I could move to go to ER.  I couldn't lay down to stop the spinning it got worse. went to recliner and it wasn't as severe   Time went on and I started feelin better.  Totally is was a 5 hour trauma for me.  FYI
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Three hours after shot I started getting dizzy.  For 4 hours after I was Extremely dizzy, vomited, bad shaking chills.  It was so sever I wanted to go to ER and be put unconsious.  My husband made so many calls for information on help and no one answered until this morning March 2.  I didn't feel that I could move to go to ER.  I couldn't lay down to stop the spinning it got worse. went to recliner and it wasn't as severe   Time went on and I started feelin better.  Totally is was a 5 hour trauma for me.  FYI
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Pyrexia, Tremor
Clinical narrative: I woke up around 1:30 in the morning I had fever and chills (100.3 temperature), and shaking. When I checked my temperature at 7:30 AM and it was 100.7. I have a slight headache and injection site pain.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Crying, Rash, Rash pruritic, Scab, Swelling face
Clinical narrative: Started with slight itchy rash on Feb 27 on right side of face. Became more itchy and spread on Feb 28.  Face swollen to almost eye shut by Mar 1, very itchy and weepy. Rash also visible on neck and front of torso.               Visited doctors office on Mar 1 at 1:00pm. Received prescription for Prednizone 20mg, to be taken over 10 days.  Seems to be working, swelling is down and not as severely itching. Still very visable and dry crust forming on face.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Pyrexia
Clinical narrative: Fever, chills, aching joints, fatigue
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: Moderate pain from elbow to collarbone that is getting better with time. Still hurting today (03/07/21)
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Deafness, Ear discomfort, Tinnitus
Clinical narrative: Awoke 02/04/2021 with sudden hearing loss of left ear.  He had "static" type noise and pressure in left ear. Static noise resolved after a few hours but left with hearing loss.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Headache
Clinical narrative: Severe back pain-subside after  3 days but still ongoing -Frontal lobe Headache - lasted for 3days.  -Joint pain - lasted for 24 hrs. Chills- lasted for 2 days. Treated with Ibuprofen, Tylenol and rest
Age: 71.0
Sex: U
Vaccine: COVID19
Symptoms: Flushing, Palpitations
Clinical narrative: FLUSHING, PALPUTATIONS EVALUATED BY EMS AND CLEARED
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pruritus, Injection site reaction, Rash macular
Clinical narrative: splotchy red area around the vaccine site and slightly itchy.  Pain in left shoulder blade
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Bad rash under both arm pits. I'm on day 4 of the rash right now.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Hypoaesthesia oral, Lethargy
Clinical narrative: Tongue and right side of face went numb within minutes of receiving in right arm. Continued getting worse. After getting home, I waited 2 hours and took Benadryl and went to bed. Morning still numb but better. Feels like I can?t taste on that side. Also have a headache and just overall feeling lethargic.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: COVID Dose 1 was Pfizer Lot EL3249.     Recipient presented without card to a Moderna event and had belief that Moderna was first dose.  Further research after the vaccination event revealed he had Pfizer first dose and subsequent Moderna second dose.  No additional adverse effect noted.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: death
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysphagia, Dyspnoea, Throat tightness
Clinical narrative: was OK 15 minute wait.  Driving home I felt like I was going to pass out, my throat tightened and I could not swallow then I had difficulty breathing.  Called 911 and police met us first.  Breathing returned to normal then it happened again about 5 minute later with feeling of passing out and breathing/swallowing issues.  Ambulance came and was taken to the ER.  Given predinesone and benedryl and monitored.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site rash, Pain in extremity
Clinical narrative: Patient called Heath Department 3/1/2021 to report she is experiencing light pain in her left arm where she received the COVID-19 vaccine. The pain started around 2/19/21 and has improved but still present. On 2/28/21 patient noticed a red rash about the size of a half dollar at the injection site. She had not looked at site prior and is unsure if rash was present earlier. Patient asked me to report to VAERS as she does not have internet access and would prefer not to make the phone call herself.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Blood test, Computerised tomogram, Corneal reflex decreased, Dyskinesia
Clinical narrative: 1/8 vaccination *1-8-1/11 I felt fine 1/12 7am, when i woke up my eye was goopy, sticky, L eye. I could not blink. I noticed more problems later in the day; my mouth wasn't working properly (couldn't eat properly). I tried to call and make appt with PCP.  Informed to go smile in front of mirror, my smile was sagging on L side. Informed to call 911.  TX to hospital,  for possible stroke.   Dr. ran tests Dr. audio / visual consult *diagnosed with Bells Palsy  1/21 started to feel better  **2/5/2021 2nd vaccination
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Eye discharge
Clinical narrative: 1/8 vaccination *1-8-1/11 I felt fine 1/12 7am, when i woke up my eye was goopy, sticky, L eye. I could not blink. I noticed more problems later in the day; my mouth wasn't working properly (couldn't eat properly). I tried to call and make appt with PCP.  Informed to go smile in front of mirror, my smile was sagging on L side. Informed to call 911.  TX to hospital,  for possible stroke.   Dr. ran tests Dr. audio / visual consult *diagnosed with Bells Palsy  1/21 started to feel better  **2/5/2021 2nd vaccination
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Dizziness, Dysarthria, Facial paralysis, Somnolence
Clinical narrative: Per patient's report:  She received her first dose of Pfizer COVID-19 vaccine and developed soreness at localized injection site and felt sleepy, otherwise no adverse reaction signs or symptoms patient reported. On 2-19-21 at 2:30 PM she received her second dose of the Pfizer COVID-19 vaccine at a mall.  She reports the lot number of the vaccine was EL9269. She was monitored for 15 minutes after receiving the second dose.  She and her husband left and took the car to a car wash where she fell asleep on her way home and her husband woke her up when they got home.  At about 320 or 3:25 PM, she noticed that her face felt puffy and she had a sensation that her face was sliding down, she developed tongue swelling, blurry vision, dizziness, and she reports that she was talking funny/slurring her words.  Her husband got a flashlight and looked in her throat and said that her throat was swelling.  She felt like falling asleep.  Her husband used her EpiPen on her.  The EpiPen worked right away to improve the symptoms.  She took no other treatments at home.  Her husband drove her to the hospital where she slept the entire way.  She never developed rash, flushing, skin itching, wheezing, coughing, chest tightness, shortness of breath, nausea, vomiting, diarrhea, fevers, chills, or joint pains.  She does not know if she passed out, she states it was hard to stay awake.  She reports having some abdominal cramping and churning for the following 2 to 3 days afterwards.  She was discharged from the hospital ED where she was never admitted.  They gave her an albuterol inhaler to use every 4 hours for 6 days after she left the ED.  She went home at about 10:00 PM and went to bed about 10:30 PM.  She woke up at 3:00 AM crying and then fell back asleep and woke up again around 7:30 AM.  She did not develop any local injection site reactions on her arm this time.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Swollen tongue, Vision blurred
Clinical narrative: Per patient's report:  She received her first dose of Pfizer COVID-19 vaccine and developed soreness at localized injection site and felt sleepy, otherwise no adverse reaction signs or symptoms patient reported. On 2-19-21 at 2:30 PM she received her second dose of the Pfizer COVID-19 vaccine at a mall.  She reports the lot number of the vaccine was EL9269. She was monitored for 15 minutes after receiving the second dose.  She and her husband left and took the car to a car wash where she fell asleep on her way home and her husband woke her up when they got home.  At about 320 or 3:25 PM, she noticed that her face felt puffy and she had a sensation that her face was sliding down, she developed tongue swelling, blurry vision, dizziness, and she reports that she was talking funny/slurring her words.  Her husband got a flashlight and looked in her throat and said that her throat was swelling.  She felt like falling asleep.  Her husband used her EpiPen on her.  The EpiPen worked right away to improve the symptoms.  She took no other treatments at home.  Her husband drove her to the hospital where she slept the entire way.  She never developed rash, flushing, skin itching, wheezing, coughing, chest tightness, shortness of breath, nausea, vomiting, diarrhea, fevers, chills, or joint pains.  She does not know if she passed out, she states it was hard to stay awake.  She reports having some abdominal cramping and churning for the following 2 to 3 days afterwards.  She was discharged from the hospital ED where she was never admitted.  They gave her an albuterol inhaler to use every 4 hours for 6 days after she left the ED.  She went home at about 10:00 PM and went to bed about 10:30 PM.  She woke up at 3:00 AM crying and then fell back asleep and woke up again around 7:30 AM.  She did not develop any local injection site reactions on her arm this time.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Gait disturbance, Pain, Vertigo
Clinical narrative: VAX #1 - NO IMMEDIATE SYMPTOMS AT ALL.  12 DAYS AFTER THE VACCINE #1, I WOKE UP AND WAS VERY DIZZY AND FELL BACK INTO BED. EVENTUALLY ABLE TO WALK WITH HOLDING ONTO FURNITURE. LATER THAT DAY, NEURO EXAM CONSISTENT WITH POSITIONAL VERTIGO. NO HISTORY OF VERTIGO. EPLEY MAUEVER AND SOME IMPROVEMENT OVER THE NEXT FEW DAYS.  SECOND VACCINATINO RESULTED IN A FEW HOURS OF TYPICAL SYMPTOMS OF ACHES, ETC. THE FOLLOWING MORNING AND FOR THE NEXT WEEK THERE WAS  AN INCREASE IN THE VERTIGO. THIS PERSISTS AS OF TODAY, ALTHOUGH  I AM 90% BETTER OVERALL. i DO HAVE TO BE MINDFUL AND CAREFUL WITH HEAD MOVEMENTS  THAT PROVOKE VERTIGO.  THROUGHOUT ALL OF THE VERTIGO, I  HAVE DONE  'EXERCISES' TO IMPROVE SYPMTOMS AND CONTINUE TO DO SO.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site erythema, Injection site mass, Injection site pruritus
Clinical narrative: Day 1 and 2 no redness or swelling at site.  Slight headache and chills day 1.  Day 3 swelling, redness and itching at site.  No improvement on day 7.  No pain associated or other symptoms.  Just red, itchy, and large lump above injection site.  Using Benadryl  cream on the site.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling
Clinical narrative: Day 1 and 2 no redness or swelling at site.  Slight headache and chills day 1.  Day 3 swelling, redness and itching at site.  No improvement on day 7.  No pain associated or other symptoms.  Just red, itchy, and large lump above injection site.  Using Benadryl  cream on the site.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA Mild diabetic reaction (light-headed, dizziness) to the sucrose, lasting the same afternoon, through the night, and all the next day.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Menstruation irregular, Muscle spasms
Clinical narrative: I began menstruating after no menstruation cycle?s for one year.  I also experience headache and cramping.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Hypertension, Paraesthesia oral, Periorbital swelling
Clinical narrative: In the clinic, patient received second dose of Moderna vaccine at 1630. At 16:40 c/o difficulty breathing, feeling light headed, tingling lips, eyes puffy. BP 187/77, HR 84, O2 Sat=84. Rapid Response Team (RRT) activated, patient took Benadryl 25mg PO,symptoms not improving, transported to the ED via stretcher with the RRT.   In the ED, patient presented afebrile, hemodynamically stable, no acute distress. Physical exam overall unrevealing. No apparent hives, facial swelling, oropharyngeal swelling or wheeze. Patient stated the symptoms feel significantly better.   Patient given 25 mg Benadryl and 20 mg famotidine via IV. Observed in the emergency department for almost 3 hours. No resurgence of symptoms, no rash, no wheeze, no nausea or vomiting. Patient discharged home, advised to take another dose of Benadryl later at night, and reevaluate symptoms in the morning. Advised to follow-up promptly with primary care. Strict return precautions given.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Headache, Heart rate increased, Hypoaesthesia oral, Injection site pain
Clinical narrative: Had the injection Friday evening. Very quickly had my heart rise and felt shaky (like when you take an inhaler). Heart rate stayed up for about 30 min, shaky for about another 1 and half.  but left factily after 15 minutes, as I was shaky, but ok.  About 20 min after shot, the tip of my tongue and lips got tingly/numbish. Not swollen, just tingly.  (They were very slightly the same way the next day). I went home and contacted  hotline. She suggested I call a dr. I called a dr who told me to take a benadryl.  I ate some food and took the benadryl. I fell asleep and slept for 14 hours (definitely not normal). That next day (Saturday) I had a headache, upset stomach, lowgrade fever (below 99.9) and pretty good pain in the injection arm. Stomach was settled by that evening, headache was gone Sunday. Off and on low grade fever (highest was 100.3) still ongoing (Tues 3/2, but highest today is 99.1))